Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis | Dermatology | JAMA Dermatology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.153.100.128. Please contact the publisher to request reinstatement.
Observation
April 2016

Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis

Author Affiliations
  • 1Albany Medical College, Albany, New York
  • 2Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut
JAMA Dermatol. 2016;152(4):492-493. doi:10.1001/jamadermatol.2015.3772
×